Immunotherapy combo shows promise for Hard-to-Treat stomach cancers
NCT ID NCT03257163
First seen Jan 25, 2026 · Last updated May 08, 2026 · Updated 12 times
Summary
This study is for people with specific types of stomach cancer (mismatch repair deficient or Epstein-Barr virus positive) that can be surgically removed. It tests whether giving the immunotherapy drug pembrolizumab before and after standard chemotherapy and radiation can help prevent the cancer from coming back. About 40 participants will receive this combination treatment and be followed for three years to see how well it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University
Atlanta, Georgia, 30308, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
Hamilton, New Jersey, 08690, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
Conditions
Explore the condition pages connected to this study.